IMM 0.00% 34.0¢ immutep limited

prr in it most recent presentation estimated the ovarian cancer...

  1. 299 Posts.
    prr in it most recent presentation estimated the ovarian cancer treatment vaccine market to be $3,600 million and state it may capture 10% of the market in first year on market with revenue of $500 million. obviusly ppr anticipate market may grow by $1,400 million in coming years.

















 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.